Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004850431 | SCV005469309 | uncertain significance | not specified | 2024-06-26 | criteria provided, single submitter | clinical testing | The c.68C>T (p.P23L) alteration is located in exon 2 (coding exon 1) of the PIGC gene. This alteration results from a C to T substitution at nucleotide position 68, causing the proline (P) at amino acid position 23 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |